Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heparin-induced thrombocytopenia

V A Fahey

    Journal of Vascular Nursing : Official Publication of the Society for Peripheral Vascular Nursing
    |December 1, 1995
    PubMed
    Summary
    This summary is machine-generated.

    Heparin-induced thrombocytopenia (HIT) is a rare but serious complication of heparin therapy. Early detection and nursing assessment are crucial for preventing severe outcomes like thrombosis and bleeding.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Extraanatomic bypass surgery.

    Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing·2000
    Same author

    Advances in diagnostic testing for vascular disease.

    Cardio-vascular nursing·1989
    Same author

    An in-depth look at deep vein thrombosis.

    Nursing·1989
    Same author

    Improved long-term patency of infragenicular polytetrafluoroethylene grafts.

    Journal of vascular surgery·1988
    Same author

    Thoracic outlet syndrome.

    The Journal of cardiovascular nursing·1987
    Same author

    The reoperative potential of infrainguinal bypass: long-term limb and patient survival.

    Journal of vascular surgery·1987

    Area of Science:

    • Pharmacology
    • Hematology
    • Immunology

    Background:

    • Heparin is a widely used anticoagulant, prescribed over 1 trillion units annually in the US.
    • A rare but severe complication, heparin-induced thrombocytopenia (HIT), presents significant morbidity and mortality risks.
    • HIT involves thrombocytopenia, thrombosis (venous or arterial), and potential bleeding, linked to an immune response against heparin.

    Purpose of the Study:

    • To discuss the clinical presentation and management of heparin-induced thrombocytopenia.
    • To highlight the critical role of nurses in the early detection and prevention of HIT complications.
    • To emphasize the importance of assessing all patients receiving heparin therapy.

    Main Methods:

    • Literature review on heparin-induced thrombocytopenia mechanisms and treatments.

    Related Experiment Videos

  • Discussion of clinical manifestations and diagnostic considerations.
  • Emphasis on nursing assessment protocols for patients on heparin.

    • Main Results:

    • Heparin-induced thrombocytopenia is an immune-mediated condition causing platelet consumption.
    • Discontinuation of heparin is the primary treatment, with alternative therapies also discussed.
    • Early identification by nurses can mitigate severe complications.

    Conclusions:

    • Heparin-induced thrombocytopenia is a serious adverse drug event requiring vigilant monitoring.
    • Nurses play a pivotal role in the early detection and management of HIT.
    • Proactive patient assessment is essential for all individuals receiving heparin therapy.